The EAU guidelines recommends offering early PSA testing for men with elevated risk of Pca; these include men over 50 years of age, men over 45 years of age with a family history of Pca, and African-Americans over 45 years of age [2]. Here, KLK3 is linked to posterior cortical atrophy.